IRBESARTAN/HCTZ
SANIS HEALTH INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of IRBESARTAN/HCTZ in Canada?
Yes. IRBESARTAN/HCTZ 12.5MG 300MG has an active shortage reported to Health Canada (last updated October 8, 2024).
Why is IRBESARTAN/HCTZ not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will IRBESARTAN/HCTZ be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02372894
Strength
12.5MG 300MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
HYDROCHLOROTHIAZIDE IRBESARTAN
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from SANIS HEALTH INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02286254
400MG · DIN 02286262
100MG · DIN 02286246
400MG · DIN 02286564
70MG · DIN 02352966
10MG · DIN 02519844
12.5MG · DIN 02466821
0.50MG · DIN 02349205
0.25MG · DIN 02349191
200MG · DIN 02364336
10MG · DIN 02331292
5MG · DIN 02331284